PMC:7267243 / 13419-13595 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"411","span":{"begin":146,"end":154},"obj":"Species"},{"id":"413","span":{"begin":39,"end":50},"obj":"Species"},{"id":"414","span":{"begin":87,"end":100},"obj":"Chemical"},{"id":"419","span":{"begin":133,"end":141},"obj":"Disease"}],"attributes":[{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"Tax:9606"},{"id":"A413","pred":"tao:has_database_id","subj":"413","obj":"Tax:746128"},{"id":"A414","pred":"tao:has_database_id","subj":"414","obj":"MESH:C012990"},{"id":"A419","pred":"tao:has_database_id","subj":"419","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T25","span":{"begin":116,"end":121},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"fma_id","subj":"T25","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T19","span":{"begin":116,"end":121},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T141","span":{"begin":133,"end":141},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T95","span":{"begin":11,"end":18},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T110","span":{"begin":87,"end":100},"obj":"Chemical"}],"attributes":[{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T6","span":{"begin":72,"end":82},"obj":"http://purl.obolibrary.org/obo/GO_0046903"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T8","span":{"begin":87,"end":100},"obj":"GlycoEpitope"}],"attributes":[{"id":"A8","pred":"glyco_epitope_db_id","subj":"T8","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}

{"project":"LitCovid-sentences","denotations":[{"id":"T153","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, testing for the presence of Aspergillus in lower respiratory secretions and galactomannan in consecutive serum samples in COVID‐19 ICU patients should be considered."}